Ride the Relief Rally: Jazz Pharmaceuticals Long Trade After Oxybate Outlook Brightens
Jazz Pharmaceuticals is trading up sharply after pipeline and competitive developments have reduced near-term regulatory and commercial overhang for its oxybate franchise. The setup offers a momentum swing with defined risk: entry near the breakout, stop under key technical support, and a target that captures re-rating possibilities as free cash fl…